Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dry granulation formulation for an HIV protease inhibitor

Dry granulation formulation for an HIV protease inhibitor

US Patent 6645961 · Granted Nov 11, 2003

Estimated economic value: $41,694,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulations of tegavivint2025
Crystalline form of tegavivint, method of preparation, and use thereof2025
Lyophilized formulations of tegavivint2025
Stable aqueous capsaicin injectable formulations and medical uses thereof2024
Formulations of tegavivint2024
Lyophilized formulations of tegavivint2023
Enhanced solubility drug-containing formulations2023
Lyophilized formulations of tegavivint2023
Lyophilized formulations of tegavivint2023
Stable aqueous capsaicin injectable formulations and medical uses thereof2022
Method of administering amantadine prior to a sleep period2021
Crystalline form of tegavivint, method of preparation, and use thereof2021